A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide® ISA-51 in Patients With Cancer.
NCT00199836
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
14
Enrollment
OTHER
Sponsor class
Conditions
Cancer
Neoplasm
Interventions
BIOLOGICAL:
NY-ESO-1b peptide plus CpG 7909 and Montanide® ISA-51
Sponsor
Ludwig Institute for Cancer Research